Adbiotech Co (XKRX:179530) ROCE % : -140.09% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Adbiotech Co's annualized ROCE % for the quarter that ended in Mar. 2024 was -140.09%.

Adbiotech Co ROCE % Historical Data

The historical data trend for Adbiotech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co ROCE % Chart

Adbiotech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-110.24

-21.08

20.47

-29.31

Adbiotech Co Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial									-10.67	-9.40	-25.97	-74.60	-140.09

Adbiotech Co ROCE % Calculation

Adbiotech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-5031.041	/	( ( (31018.134 - 11792.679)	+	(28093.228 - 12989.634) )	/ 2 )
	=	-5031.041	/	( (19225.455	+	15103.594)	/ 2 )
	=	-5031.041	/	17164.5245
	=	-29.31 %

Adbiotech Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-17701.52	/	( ( (28093.228 - 12989.634)	+	(22896.225 - 12727.494) )	/ 2 )
	=	-17701.52	/	( ( 15103.594	+	10168.731 )	/ 2 )
	=	-17701.52	/	12636.1625
	=	-140.09 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Adbiotech Co (XKRX:179530) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Adbiotech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Adbiotech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adbiotech Co (XKRX:179530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398

Website

http://www.adbiotech.com

Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines